Positive trial data for NewCardio's wireless ECG monitor
This article was originally published in Clinica
Executive Summary
Two validation studies of CardioBip, a hand-held device that allows patients to record and wirelessly transmit echocardiograms (ECGs), have had "encouraging" results.
You may also be interested in...
ITF Has A Fight On Its Hands In Duchenne
The group’s new muscular dystrophy pill seems unlikely to cut into Sarepta’s sales.
AbbVie Needs To Freshen Up
With half of its 2023 sales coming from aging blockbusters like Humira and Botox, AbbVie needs new blood.
AstraZeneca Pays $2bn To Keep Up With The Joneses
Bristol Myers Squibb and Lilly have recently done billion-dollar radiopharmaceuticals deals, and now the UK group wants a piece of the market. But can it make its Fusion fusion work?